KR101952078B1 - Food composition for controlling body weight - Google Patents
Food composition for controlling body weight Download PDFInfo
- Publication number
- KR101952078B1 KR101952078B1 KR1020180098993A KR20180098993A KR101952078B1 KR 101952078 B1 KR101952078 B1 KR 101952078B1 KR 1020180098993 A KR1020180098993 A KR 1020180098993A KR 20180098993 A KR20180098993 A KR 20180098993A KR 101952078 B1 KR101952078 B1 KR 101952078B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- powder
- food composition
- food
- composition
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000037396 body weight Effects 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 34
- 230000004584 weight gain Effects 0.000 claims abstract description 21
- 235000019786 weight gain Nutrition 0.000 claims abstract description 21
- 229930091371 Fructose Natural products 0.000 claims abstract description 17
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 17
- 239000005715 Fructose Substances 0.000 claims abstract description 17
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 11
- 229940001941 soy protein Drugs 0.000 claims abstract description 6
- 235000014510 cooky Nutrition 0.000 claims description 21
- 239000000796 flavoring agent Substances 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 12
- 102000011632 Caseins Human genes 0.000 claims description 10
- 108010076119 Caseins Proteins 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 235000012907 honey Nutrition 0.000 claims description 8
- 235000013376 functional food Nutrition 0.000 claims description 7
- 229940080237 sodium caseinate Drugs 0.000 claims description 5
- 235000019710 soybean protein Nutrition 0.000 claims description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 210000003205 muscle Anatomy 0.000 abstract description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract description 6
- 239000005018 casein Substances 0.000 abstract description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract description 6
- 235000021240 caseins Nutrition 0.000 abstract description 6
- 239000011734 sodium Substances 0.000 abstract description 6
- 229910052708 sodium Inorganic materials 0.000 abstract description 6
- 244000299461 Theobroma cacao Species 0.000 description 25
- 235000009470 Theobroma cacao Nutrition 0.000 description 23
- 235000016709 nutrition Nutrition 0.000 description 18
- 235000015097 nutrients Nutrition 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 238000004260 weight control Methods 0.000 description 5
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 235000000053 special nutrition Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 208000037063 Thinness Diseases 0.000 description 2
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000018773 low birth weight Diseases 0.000 description 2
- 231100000533 low birth weight Toxicity 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000005974 protein supplement Nutrition 0.000 description 2
- 229940116540 protein supplement Drugs 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 206010048828 underweight Diseases 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 231100000716 Acceptable daily intake Toxicity 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009548 growth disturbance Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/16—Vegetable proteins from soybean
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 체중 증가용 식품 조성물에 관한 것으로, 분리대두단백, 결정과당분말, 카제인나트륨 및 멀티비타민을 포함하는 상기 식품 조성물은 부작용은 없으면서 체중 및 근육량을 증가시키는 효능이 있으므로, 저체중 상태의 소아, 청소년 및 성인을 위한 체중 증가 용도로 유용하게 사용될 수 있다.The present invention relates to a food composition for weight gain, wherein the food composition comprising isolated soy protein, fructose fructose powder, casein sodium and multivitamins has the effect of increasing body weight and muscle mass without side effects, Can be useful for weight gain applications for adolescents and adults.
Description
본 발명은 분리대두단백, 결정과당분말, 카제인나트륨 및 멀티비타민을 포함하는 체중 조절용 식품 조성물에 관한 것이다.The present invention relates to a food composition for weight control comprising isolated soy protein, crystalline fructose powder, sodium caseinate and multivitamins.
산업화와 식습관 변화로 인하여 많은 현대인들이 비만으로 건강을 위협받고 있지만, 반대로 저체중으로 인하여 고민하는 사람들도 많이 존재한다. 저체중인 사람은 면역계가 약화되어 결핵, 간염 및 감기 등의 감염성 질환에 걸리기 쉽고, 빈혈, 골다공증, 생식문제 및 영양 결핍 등의 위험이 증가한다. 특히 소아기에 저체중이 지속되면 성장장애를 유발할 수 있으며, 사춘기의 2차 성징에 영향을 미치고, 골 성숙도에 문제를 유발하여 키 성장에 악영향을 미치게 된다. 또한, 저체중인 사람은 연령이 증가할수록 사망률이 증가하기 때문에 체격에 맞는 정상 체중을 유지하는 것은 비만 문제만큼이나 중요한 사회적 문제이다.Many modern people are threatened by obesity due to industrialization and changes in eating habits, but there are also many people who worry about underweight. People who are underweight have a weakened immune system and are susceptible to infectious diseases such as tuberculosis, hepatitis and cold, and increase the risk of anemia, osteoporosis, reproductive problems and malnutrition. Especially, low birth weight in childhood can cause growth disturbance, affects secondary puberty, and causes problems in bone maturity, which adversely affects key growth. In addition, since the mortality rate increases as the age increases, maintaining a normal weight corresponding to the physique is as important as the obesity problem.
건강하게 체중을 늘리기 위해서는 설탕과 포화지방으로 채워진 고칼로리 음식보다는 칼로리와 영양소가 골고루 포함된 음식을 선택해야 하며, 살코기, 생선, 계란 흰자, 콩, 두부, 낙농제품과 같은 단백질이 가득한 음식을 포함하는 것이 바람직하다. 단백질은 뼈 건강, 면역계 강화, 질병으로부터의 회복 등을 위해 필요하다. 하지만, 일반인들이 이러한 음식을 일일이 챙기기에는 시간과 노력이 많이 소요되고 실행이 어렵기 때문에 체중 조절용 식품이 많이 이용되고 있다.To increase your weight, you should choose foods that contain calories and nutrients rather than high-calorie foods filled with sugar and saturated fats, and include foods that are full of protein such as lean meat, fish, egg whites, beans, tofu, and dairy products . Proteins are needed for bone health, immune system enhancement, and recovery from disease. However, since it takes a lot of time and effort for the general public to take these foods, and it is difficult to implement them, weight control foods are widely used.
체중 조절용 식품은 체중조절이 필요한 사람들을 위해 식사의 일부나 전부를 대신할 수 있도록 비타민이나 무기질 등 필요한 영양소를 첨가하고 열량을 조절한 것을 말한다. 이러한 체중 조절용 식품에는 체중 감소용 식품과 체중 증가에 도움을 주는 식품, 즉 보충제가 있다. 체중 증가용 보충제에는 근육을 늘리기 위한 단백질 보충제, 체중과 근육을 함께 늘리는 단백질 및 탄수화물 보충제, 체중을 늘리기 위한 탄수화물 보충제가 있다.Weight control foods are foods that contain nutrients such as vitamins or minerals and are used to control calories to replace some or all of the diet for those who need weight control. These weight control foods include weight loss foods and food supplements to help with weight gain. Weight gain supplements include protein supplements to increase muscle, protein and carbohydrate supplements to increase body weight and muscle together, and carbohydrate supplements to increase body weight.
하지만 이러한 보충제는 특정 영양 성분의 비율이 지나치게 높기 때문에 단백질 보충제의 경우 신장질환을 유발할 수 있으며, 탄수화물 보충제의 경우 설사, 소화불량 및 복부팽만 등의 부작용이 나타날 수 있다. 따라서 부작용은 적으면서 안전하고 간편하게 이용할 수 있는 체중 증가용 식품이 필요한 실정이다.However, these supplements may cause kidney disease in protein supplements due to the high percentage of specific nutrients, and side effects such as diarrhea, indigestion and abdominal distension may occur in carbohydrate supplements. Therefore, there is a need for a food for weight gain which is safe and easy to use while having few side effects.
본 발명자들은 분리대두단백 등을 포함하는 식품 조성물이 부작용은 적으면서 체중 증가 효과가 있음을 확인하여 본 발명을 완성하였다.The inventors of the present invention completed the present invention by confirming that a food composition containing isolated soybean protein has a weight gain effect while having few side effects.
본 발명의 일 양상은 분리대두단백, 결정과당분말, 카제인나트륨 및 멀티비타민을 포함하는 체중 증가용 식품 조성물을 제공하는 것이다.One aspect of the present invention is to provide a food composition for weight gain comprising isolated soy protein, fructose fructose powder, casein sodium and multivitamins.
본 발명의 일 양상은 분리대두단백, 결정과당분말, 카제인나트륨 및 멀티비타민을 포함하는 체중 증가용 식품 조성물을 제공한다.One aspect of the present invention provides a food composition for weight gain comprising isolated soy protein, crystalline fructose powder, sodium caseinate and multivitamins.
본 발명에서 용어 '분리대두단백(soy protein isolate, ISP)'은 탈지 대두를 물 또는 미약 알칼리성 용액으로 추출하여, 추출액 중의 단백질을 pH 4 내지 5에서 등전침전시킨 단백질을 말하며, 지방, 탄수화물 및 기타 불순물을 제거하여 단백질만 약 90% 이상 남아 있다. 대두는 식물로서는 유일하게 완전한 단백질 급원이기 때문에 육류, 계란, 우유와 같은 동물성 단백질 급원과 비슷하게 품질이 우수하다. 본 발명에서 상기 분리대두단백은 단백질 공급원으로서의 역할을 하여 근육량 증가, 체중 중가에 도움을 준다.The term "soy protein isolate (ISP)" in the present invention refers to a protein obtained by extracting defatted soybean with water or a weakly alkaline solution and isoelectric precipitation of the protein in the extract at pH 4 to 5, and fat, carbohydrate and other Only about 90% of the protein is removed by removing impurities. Because soybean is the only complete source of protein for plants, it has a quality similar to that of animal protein sources such as meat, eggs, and milk. In the present invention, the isolated soybean protein serves as a protein source, which helps increase muscle mass and weight.
본 발명의 일 구체예에 의하면 상기 분리대두단백은 식품 조성물 총 중량에 대하여 20 내지 70 중량%로 포함되는 것이 바람직하고, 30 내지 60 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the isolated soy protein is preferably contained in an amount of 20 to 70% by weight, and most preferably 30 to 60% by weight based on the total weight of the food composition.
본 발명에서 용어 '결정과당'은 이당류인 설탕에서 포도당을 제외한 과당성 분말을 결정화한 것을 말하며, 결정과당은 설탕과 비교하여 적은 양으로도 단맛을 더 느낄 수 있고, 혈당 지수(glycemic index, GI)도 19 정도로 설탕의 65와 비교하여 낮은 편이다.The term 'crystalline fructose' in the present invention refers to crystallized fructose powder excluding glucose in the disaccharide sugar. Fructose fructose can feel a sweet taste even in a small amount compared with sugar and has a glycemic index (GI ) Is about 19 degrees, which is lower than 65 of sugar.
본 발명의 일 구체예에 의하면 상기 결정과당은 식품 조성물 총 중량에 대하여 5 내지 30 중량%로 포함되는 것이 바람직하고, 10 내지 20 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the fructose is preferably contained in an amount of 5 to 30% by weight, and more preferably 10 to 20% by weight based on the total weight of the food composition.
본 발명에서 용어 '카제인나트륨(sodium caseinate)'은 정제된 우유단백질로 정제하는 과정에서 물에 잘 녹지 않는 카제인의 수용성을 높이기 위하여 나트륨을 결합시킨 것을 말한다. 일반적으로 화학적 합성품으로 분류되는 물질이지만 1일 허용 섭취량을 설정하지 않을 정도로 안정성이 입증된 물질이다.The term " sodium caseinate " in the present invention refers to sodium bonded to enhance the water-solubility of casein which is insoluble in water when purified with purified milk protein. It is a substance that is generally classified as a chemical compound but has proven to be stable enough not to allow an acceptable daily intake.
본 발명의 일 구체예에 의하면 카제인나트륨은 식품 조성물 총 중량에 대하여 5 내지 20 중량%로 포함되는 것이 바람직하고, 7 내지 15 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, sodium casein is preferably contained in an amount of 5 to 20% by weight, and most preferably 7 to 15% by weight based on the total weight of the food composition.
본 발명에서 용어 '멀티비타민'은 복용의 편리성을 위하여 비타민 A, B 등의 비타민과 여러 가지 무기질을 동시에 섭취할 수 있도록 만든 것을 말하며, 비타민 및 무기질은 신체의 건강상태와 성장 및 정상적인 대사기능을 위하여 필요한 영양소이다.The term " multivitamin " in the present invention means a vitamin and a minerals such as vitamin A and B which can be taken simultaneously for convenience of taking. Vitamins and minerals are used for health and growth of the body and normal metabolism Is a nutrient needed for.
본 발명의 일 구체예에 의하면 상기 멀티비타민은 식품 조성물 총 중량에 대하여 0.5 내지 10 중량%로 포함되는 것이 바람직하고, 1 내지 7 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the multi-vitamin is preferably contained in an amount of 0.5 to 10% by weight, and more preferably 1 to 7% by weight, based on the total weight of the food composition.
본 발명의 일 구체예에 의하면 상기 체중 증가용 식품 조성물은 쿠키향분말 및 꿀분말을 추가로 포함할 수 있다.According to one embodiment of the present invention, the food composition for weight gain may further comprise a cookie-flavored powder and a honey powder.
'쿠키향분말'은 합성착향료(synthetic flavoring substances)의 일종으로, 가공식품은 제조과정에서 본래의 향기나 냄새가 거의 제거되기 때문에 향을 따로 첨가하게 되는데 천연 향료는 값이 비싸기 때문에 주로 인공 합성착향료를 사용하게 된다. 상기 쿠키향분말은 덱스트린, 쿠키향베이스 및 아라비아검이 혼합된 것일 수 있다.'Cookie fragrance powder' is a kind of synthetic flavoring substances. Since the original flavor and odor are almost eliminated during the manufacturing process, the fragrance is separately added. Since the natural flavor is expensive, the artificial synthetic flavoring agent . The cookie-flavored powder may be a mixture of dextrin, cookie flavor base, and gum arabic.
본 발명의 일 구체예에 의하면 상기 쿠키향분말은 식품 조성물 총 중량에 대하여 1 내지 10 중량%로 포함되는 것이 바람직하고, 2 내지 7 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the cookie-flavored powder is preferably contained in an amount of 1 to 10% by weight, and more preferably 2 to 7% by weight based on the total weight of the food composition.
본 발명에서 용어, '꿀분말'은 꿀을 과립 형태로 동결건조시킨 천연 감미료로 휴대와 보관이 편리한 장점이 있다. 꿀은 비타민 P가 다량 함유되어 있어 콜라겐을 만드는 비타민 C의 기능을 보강하며, 모세혈관을 튼튼하게 하고, 항균작용을 한다.In the present invention, the term 'honey powder' is a natural sweetener in which honey is lyophilized in the form of granules, which is convenient to carry and store. Honey contains a large amount of vitamin P, enhances the function of vitamin C to make collagen, strengthens capillaries, and has antibacterial action.
본 발명의 일 구체예에 의하면 상기 꿀분말은 식품 조성물 총 중량에 대하여 1 내지 10 중량%로 포함되는 것이 바람직하고, 2 내지 7 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the honey powder is preferably contained in an amount of 1 to 10% by weight, and more preferably 2 to 7% by weight, based on the total weight of the food composition.
본 발명의 일 구체예에 의하면, 상기 체중 증가용 식품 조성물은 생크림향 분말 또는 코코아분말을 추가로 함유할 수 있다.According to one embodiment of the present invention, the food composition for weight gain may further comprise a cream-flavored powder or a cocoa powder.
생크림향분말은 합성착향료의 일종으로, 상기 쿠키향분말을 포함하는 합성착향료는 화학 합성물이기 때문에 식품의약품안전처가 고시한 '식품첨가물의 기준 및 규격'에 고시된 물질을 사용하여야 한다.Since the creamy flavor powder is a kind of synthetic flavoring agent, the synthetic flavoring agent containing the above-mentioned cookie flavor powder is a chemical compound, and therefore, the substances notified in the 'Standards and Specifications of Food Additives' notified by the Food and Drug Administration shall be used.
본 발명의 일 구체예에 의하면 상기 생크림향분말은 식품 조성물 총 중량에 대하여 1 내지 10 중량%로 포함되는 것이 바람직하고, 2 내지 7 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the cream-flavored powder is preferably contained in an amount of 1 to 10% by weight, and more preferably 2 to 7% by weight, based on the total weight of the food composition.
코코아분말은 카카오열매를 볶은 후 껍질을 벗겨서 지방을 제거한 덩어리를 분말화한 것을 말하며, 카카오에는 항산화 활성이 우수한 폴리페놀, 폴리바놀과 식이섬유가 풍부하게 함유되어 있다. Cocoa powder refers to powdered cocoa powder that has been peeled off the skin after frying the cocoa beans. The cocoa powder is rich in polyphenols, polyvonols and dietary fiber, which have excellent antioxidant activity.
본 발명의 일 구체예에 의하면 상기 생크림향분말은 식품 조성물 총 중량에 대하여 5 내지 20 중량%로 포함되는 것이 바람직하고, 7 내지 15 중량%로 포함되는 것이 가장 바람직하다.According to one embodiment of the present invention, the cream-flavored powder is preferably contained in an amount of 5 to 20% by weight, and more preferably 7 to 15% by weight, based on the total weight of the food composition.
본 발명의 다른 양상은 본 발명의 식품 조성물을 포함하는 체중 증가용 기능성 식품 또는 특수영양식품을 제공한다.Another aspect of the present invention provides a functional food for weight gain or a special nutrition food comprising the food composition of the present invention.
본 발명에서 용어 '특수영양식품'은 영유아, 병약자, 노약자 또는 임산부 등 특별한 영양관리가 필요한 특정 대상을 위한 용도에 제공할 목적 또는 한 끼의 식사를 대용할 목적으로 식품 원료에 영양소를 가감시키거나 일상의 식이에서 부족할 수 있는 영양소를 보충할 목적으로 식품과 영양소를 배합하는 등의 방법으로 제조한 식품을 말한다. 영아용 조제식, 성장기용 조제식, 영양보충용 식품, 식사대용 식품 등이 있다.The term " special nutritional food " in the present invention means a nutritional supplement for the purpose of providing a specific purpose requiring special nutrition management such as infant, sick person, elderly person or pregnant woman, Or food prepared by mixing food and nutrients for the purpose of supplementing nutrients that may be lacking in daily diet. Infant formulas, growth formulas, nutritional supplement foods, and food substitutes.
본 발명에 따른 식품 조성물은 기능성 식품에 그대로 첨가되거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그의 사용 목적(예방 또는 개선용)에 따라 적합하게 결정될 수 있다. 상기 기능성 식품의 종류에는 특별한 제한은 없다. 상기 식품의 예로는 음료, 육류, 소세지, 빵, 비스켓, 떡, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 기능성 식품을 모두 포함한다.The food composition according to the present invention can be added directly to the functional food or can be used together with other food or food ingredients and suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to its use purpose (for prevention or improvement). There is no particular limitation on the kind of the functional food. Examples of the food include dairy products including beverages, meat, sausage, bread, biscuits, rice cakes, chocolates, candies, snacks, confectionery, pizza, ramen noodles, gums, ice cream, soups, And a combination thereof, all of which contain functional foods in a conventional sense.
본 발명의 기능성 식품 중에서 음료는 지시된 비율로 필수 성분으로서 상기 조성물을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.Among the functional foods of the present invention, the beverage is not particularly limited to the other components other than those containing the above-mentioned composition as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates as additional ingredients such as ordinary beverages. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin and the like, and sugar alcohols such as xylitol, sorbitol and erythritol. Natural flavors (tau martin, stevia extracts (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above .
상기 외에 본 발명의 기능성 식품 및 특수영양식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있으며, 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 식품 조성물 100 중량% 당 0 내지 약 20 중량%의 범위에서 선택되는 것이 일반적이다.In addition to the above, the functional food and the special nutrition food of the present invention can be used as a nutritive, a vitamin, a mineral (electrolyte), a flavoring agent such as a synthetic flavor agent and a natural flavor agent, a colorant and an aggravating agent (cheese, chocolate etc.) Salts of alginic acid and its salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks and the like. These ingredients may be used independently or in combination, and the proportion of such additives is not so critical, but is generally selected in the range of 0 to about 20 weight percent per 100 weight percent of the food composition of the present invention.
본 발명에 따른 분리대두단백, 결정과당분말, 카제인나트륨 및 멀티비타민을 포함하는 체중 증가용 식품 조성물은 부작용은 없으면서 영양불균형 등으로 발생하는 저체중을 예방하고 개선시키는 효능이 있으므로, 저체중 상태의 소아, 청소년 및 성인을 위한 체중 증가 용도로 유용하게 사용될 수 있다.The food composition for weight gain comprising the isolated soybean protein, fructose fructose powder, casein sodium and multivitamins according to the present invention has the effect of preventing and improving low birth weight caused by nutritional imbalance without side effects, Can be useful for weight gain applications for adolescents and adults.
도 1은 코코아 또는 쿠키 영양쉐이크를 공급하여 사육한 마우스의 체중을 측정한 결과를 나타낸 그래프이다.
도 2는 코코아 또는 쿠키 영양쉐이크를 공급하여 사육한 마우스에서 체중 증가율(%)을 비교한 결과를 나타낸 그래프이다.
도 3은 코코아 또는 쿠키 영양쉐이크를 공급하여 사육한 마우스에서 일당 평균 증체량(g)을 비교한 결과를 나타낸 그래프이다.
도 4는 코코아 또는 쿠키 영양쉐이크를 공급하여 사육한 마우스에서 일당 평균 섭취량(g)을 비교한 결과를 나타낸 그래프이다.
도 5는 코코아 또는 쿠키 영양쉐이크를 공급하여 사육한 마우스에서 식이효율을 비교한 결과를 나타낸 그래프이다.
도 6은 코코아 또는 쿠키 영양쉐이크를 공급하여 사육한 마우스에서 등지방 두께(%)를 비교한 결과를 나타낸 그래프이다.Fig. 1 is a graph showing the results of measurement of body weight of a mouse fed with cocoa or cookie nutrient shake.
FIG. 2 is a graph showing the results of comparing weight gain (%) in mice fed with cocoa or cookie nutrient shakes.
3 is a graph showing the results of comparing average daily gain (g) in mice fed with cocoa or cookie nutrient shakes.
FIG. 4 is a graph showing the results of comparing average daily intake (g) in mice fed with cocoa or cookie nutrient shakes.
FIG. 5 is a graph showing the results of a comparison of dietary efficiency in mice fed with cocoa or cookie nutrient shakes.
FIG. 6 is a graph showing the results of comparing the backfat thickness (%) in breeding mice fed with cocoa or cookie nutrient shakes.
이하 하나 이상의 구체예를 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 하나 이상의 구체예를 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, one or more embodiments will be described in more detail by way of examples. However, these embodiments are intended to illustrate one or more embodiments, and the scope of the present invention is not limited to these embodiments.
제조예Manufacturing example 1: 체중 증가용 식품(코코아 및 쿠키 1: Food for weight gain (cocoa and cookies 영양쉐이크Nutritional shake )의 제조)
코코아 영양쉐이크 및 쿠키 영양쉐이크를 하기와 같이 제조하였다.Cocoa nutritional shake and cookie nutritional shake were prepared as follows.
결정과당분말 160g, 멀티비타민 4g, 꿀분말 4g, 쿠키향분말 4g, 염화칼륨 1g 및 이산화규소 1g을 잘 혼합한 후 100 메쉬(mesh) 채망으로 여과하여 균질화 시켰다. 다음으로 균질화시킨 혼합물에 분리대두단백 46g, 카제인나트륨 12g 및 코코아분말 12g을 첨가한 후 더블콘 혼합기(제이아이텍, 대한민국)를 이용하여 60분 동안 혼합하여 코코아 영양쉐이크를 제조하였다.160 g of crystalline fructose powder, 4 g of multi-vitamin, 4 g of honey powder, 4 g of cookie-flavored powder, 1 g of potassium chloride and 1 g of silicon dioxide were well mixed and homogenized by filtration through a 100-mesh sieve. Next, 46 g of isolated soybean protein, 12 g of casein sodium and 12 g of cocoa powder were added to the homogenized mixture, and the mixture was mixed for 60 minutes using a double cone mixer (JITECH, Korea) to prepare a cocoa nutritional shake.
상기 코코아 영양쉐이크의 제조방법과 동일한 방법을 사용하여 쿠기 영양쉐이크를 제조하였다.A cook nourishing shake was prepared using the same method as the above cocoa nutritional shake.
코코아 및 쿠키 영양쉐이크에 포함된 원료 성분을 하기 표 1 및 2에 기재하였으며, 각 성분은 에이아이코리아에프에스(서울, 대한민국)를 통하여 구입하였다.The raw ingredients contained in the cocoa and cookie nutritional shake are listed in Tables 1 and 2, and each ingredient was purchased through AA Korea FPS (Seoul, Korea).
실험예Experimental Example 1: 코코아 및 쿠키 1: Cocoa and Cookies 영양쉐이크의Nutritional shake 섭취 효능 확인 Confirm ingestion efficacy
코코아 또는 쿠키 영양쉐이크의 섭취에 의한 체중증가 효과 및 생화학적 변화를 확인하기 위하여 하기와 같이 실험하였다.In order to confirm the effect of weight gain and biochemical change due to ingestion of cocoa or cookie nutritional shake, the following experiment was conducted.
2-1: 코코아 또는 쿠키 2-1: Cocoa or cookies 영양쉐이크의Nutritional shake 투여 administration
6주령의 수컷 ICR 마우스(오리엔트 바이오, 대한민국)를 구입하여 실험실에서 1주일 동안 사육한 후 실험에 사용하였다. 사육장은 12시간 명암주기, 실내온도 22 내외 및 습도 60% 내외로 유지하였다. 급수는 일반 상수도를 사용하였고, 사료 및 급수는 제한하지 않고 사육하였다.A 6-week-old male ICR mouse (Orient Bio, Korea) was purchased and used for the experiment after one week in the laboratory. The breeding grounds were maintained at 12 hours light intensity, room temperature 22 degrees and humidity 60%. Feed water was used in general water supply, and feed and water supply were not restricted.
적응기간을 거친 마우스를 대조군(생리 식염수를 투여한 그룹), 실험군 1(코코아 영양쉐이크를 투여한 그룹) 및 실험군 2(쿠키 영양쉐이크를 투여한 그룹)의 3개군으로 나누어, 대조군은 고형사료와 함께 생리 식염수를 공급하고, 실험군은 고형사료와 함께 분말화된 코코아 영양쉐이크 또는 쿠키 영양쉐이크를 200 ㎎/㎏/day 농도로 15일 동안 매일 경구투여 하였다. 15일째 되는 날에는 공복채혈을 위하여 고형사료를 공급하지 않았다. 대조군 및 실험군 마우스의 전장(全長) 및 체중을 하루에 한 번씩 측정하여 기록하였으며, 15일 동안 하루에 한 번씩 실험동물이 섭취한 사료양을 측정하였다.The control group was divided into three groups: control group (physiological saline group), experimental group 1 (cocoa nutritional shake group), and experimental group 2 (cookie nutritional shake group) The experimental group was orally administered powdered cocoa nutrition shake or cookie nutrition shake together with the solid feed at a concentration of 200 mg / kg / day daily for 15 days together with physiological saline. On the 15th day, solid feed was not supplied for fasting blood. The total length and body weight of the control and experimental mice were measured once a day and the amount of feed consumed by the animals was measured once a day for 15 days.
2-2: 체중 증량 효과 확인2-2: Confirmation of weight gain effect
마우스의 체중은 적응기간(0 내지 7일)을 포함한 15일의 시료 투여 기간 동안 총 16번(0 및 7 내지 21일) 측정하여 기록하였다.The mice were weighed for a total of 16 times (0 and 7 to 21 days) during the 15-day sample administration period including the adaptation period (0 to 7 days).
그 결과, 하기 표 3 및 도 1에 나타난 바와 같이 대조군 및 두 실험군 모두 체증이 증가한 것을 확인하였으며, 쿠키 영양쉐이크를 투여한 실험군 2의 체중이 가장 크게 변화한 것을 알 수 있었다.As a result, as shown in the following Table 3 and FIG. 1, it was confirmed that the control group and the two experimental groups showed an increase in congestion, and the weight of the experimental group 2 to which the cookie nutritious shake was administered showed the greatest change.
상기 체중 변화를 하기 수학식 1에 따라 체중 증가율로 환산한 결과, 도 2에 나타난 바와 같이 실험군 1은 6.17%, 실험군 2는 8.64%의 체중 증가 효과가 있는 것을 확인할 수 있었다.As shown in FIG. 2, the body weight change was converted into weight increase rate according to the following equation (1). As a result, it was confirmed that weight gain was 6.17% in experimental group 1 and 8.64% in experimental group 2.
또한, 일당 평균 증체량(average daily gain, ADG)을 산출한 결과 도 3에 나타난 바와 같이 대조군, 실험군 1 및 실험군 2에서 각각 0.11 g, 0.14 g 및 0.2 g인 것을 알 수 있었으며, 대조군과 비교하여 실험군 1은 일당 평균 증체량이 25% 높고, 실험군 2는 75% 높은 것을 확인하였다.As shown in FIG. 3, the average daily gain (ADG) was 0.11 g, 0.14 g and 0.2 g in the control group, the experimental group 1 and the experimental group 2, respectively, 1 showed a 25% higher average daily gain and 75% higher in the experimental group 2.
아울러, 마우스의 일당 평균 섭취량(average daily feed intake, ADFI)을 확인한 결과 도 4에 나타난 바와 같이 대조군이 5.42±0.21 g, 실험군 1이 5.48±0.11 g 및 실험군 2가 4.76±0.23 g인 것을 확인하였다.As a result of confirming the average daily feed intake (ADFI) of the mice, it was confirmed that the control group was 5.42 ± 0.21 g, the experimental group 1 was 5.48 ± 0.11 g, and the experimental group 2 was 4.76 ± 0.23 g as shown in FIG. 4 .
상기 결과를 통하여 대조군과 실험군 1은 일당 평균 섭취량이 유사하고, 실험군 2는 대조군과 실험군 1에 비해 일당 평균 섭취량이 비교적 적은 것을 알 수 있었다.As a result, the average daily intake was similar in the control group and the experimental group 1, and the average daily intake was lower in the experimental group 2 than in the control group and the experimental group 1.
또한, 상기 일당 평균 증체량 및 일당 평균 섭취량을 이용하여 식이효율을 하기 수학식 2에 따라 산출하였다.Further, the dietary efficiency was calculated according to the following equation (2) using the daily average weight gain and average daily intake.
그 결과, 도 5에 나타난 바와 같이 대조군, 실험군 1 및 실험군 2의 식이효율이 각각 0.021, 0.026 및 0.042로 나타나 실험군 2에서 식이효율이 가장 높은 것을 알 수 있었으며, 대조군을 기준으로 실험군 1의 식이효율이 23.8% 높았고, 실험군 2가 약 100% 높았으며, 실험군끼리 비교할 때 실험군 1보다 실험군 2의 식이효율이 61.9% 높은 것으로 나타났다.As a result, as shown in FIG. 5, the dietary efficiencies of the control group, the experimental group 1 and the experimental group 2 were 0.021, 0.026 and 0.042, respectively, which showed that the dietary efficiency was the highest in the experimental group 2. In the control group, Was 23.8% higher than that of the control group, and that of the experimental group 2 was about 100% higher than that of the experimental group 1, which was 61.9% higher than that of the experimental group 1.
1-2: 전장 측정 및 전장 1-2: Field measurement and electric field 성장율Growth rate 분석 analysis
마우스의 전체 길이를 실험 시작시점과 종료시점에 측정하여 전장 성장 정도를 분석하였다.The overall length of the mouse was measured at the beginning and the end of the experiment to analyze the growth of the field.
그 결과 하기 표 4에 나타난 바와 같이 실험군 2에서 전장 성장이 가장 많이 일어난 것을 알 수 있었으며, 대조군과 비교하여 약 17.4% 높은 것을 확인할 수 있었다.As a result, as shown in Table 4, it was found that the maximum growth was observed in the experimental group 2 and 17.4% higher than that of the control group.
1-3: 지방, 단백질 함량 분석1-3: Fat and protein content analysis
실험 종료 후 각 마우스에서 등지방을 적출하여 증류수로 세척한 후 두께를 측정하여 평균값을 계산하였다.After the end of the experiment, the mice were washed with distilled water and the thickness was measured to calculate the average value.
그 결과 도 6에 나타나 있듯이 대조군의 평균 등지방 두께는 1.2±0.19 ㎜, 실험군 1은 1.32±0.16 ㎜, 실험군 2는 1.32±0.16 ㎜로 나타났다. 상기 결과를 통하여 대조군과 비교하여 실험군의 경우 약 10% 정도 등지방이 두꺼운 것을 확인할 수 있었다.As a result, as shown in Fig. 6, the mean isthmus thickness of control group was 1.2 ± 0.19 ㎜, 1.32 ± 0.16 ㎜ in experimental group 1, and 1.32 ± 0.16 ㎜ in experimental group 2. As a result, it was confirmed that about 10% of the experimental group was thicker than that of the control group.
또한, 마우스 후지근육에서 근단백질의 농도를 실험 종료시점에 측정하여 분석하였다. 구체적으로, 채혈 후에 마우스에서 대퇴부를 적출하여 근육조직을 파쇄하고, 완충용액을 첨가하여 조직을 용해시킨 후 BCA kit를 이용하여 제조사의 지시에 따라 단백질을정량 하였다.In addition, the concentration of muscle protein was measured and analyzed at the end of the experiment in mouse fusiform muscles. Specifically, after the blood collection, the thighs were removed from the mouse to disrupt the muscle tissue, and the tissues were dissolved by adding a buffer solution. Then, the proteins were quantified using BCA kit according to the manufacturer's instructions.
그 결과 하기 표 5에 나타나 있는 것과 같이 실험군 2의 경우 대조군과 비교하여 후지근육의 근단백질 농도가 약 3.68% 높은 것을 확인할 수 있었다.As a result, as shown in Table 5, it was confirmed that the muscle protein concentration of the fuzzy muscle of the experimental group 2 was about 3.68% higher than that of the control group.
1-4: 마우스 혈청 생화학적 분석1-4: Mouse serum biochemical analysis
영양쉐이크 급여가 완료된 시점부터 12시간 동안 마우스를 금식시킨 후, 마취하지 않고 고정틀 안에 마우스를 삽입한 다음 꼬리에서 공복혈액을 채취하였다. 채취한 혈액은 4℃ 및 3,000 rpm 조건에서 15분 동안 원심분리 하여 혈청을 분리하고, 생화학 분석 전까지 -70℃에 보관하였다. 혈액분석기기를 이용하여 마우스 혈청의 총 콜레스테롤(total cholesterol), 고밀도 지질단백질(high density lipoprotein, HDL), 트리글리세리드(triglyceride), 포도당(glucose) 및 전체 단백질(total protein)의 농도를 측정하였다. 저밀도 지질단백질(low density lipoprotein, LDL) 및 초저밀도 지질단백질(very low density lipoprotein, VLDL) 함량은 하기 수학식 3의 프라이드발트(Friedewald) 공식에 의하여 계산하였다.The mice were fasted for 12 hours from the time point when the nutrition shake was completed, and then the mouse was inserted into the fixed frame without anesthesia, and then the fasting blood was collected from the tail. The collected blood was centrifuged at 4 ° C and 3,000 rpm for 15 minutes to separate the serum and stored at -70 ° C until the biochemical analysis. The concentrations of total cholesterol, high density lipoprotein (HDL), triglyceride, glucose and total protein in mouse serum were measured using a blood analyzer. The content of low density lipoprotein (LDL) and very low density lipoprotein (VLDL) was calculated by the Friedewald formula of the following equation (3).
혈청 분석 결과를 하기 표 6에 기재하였다.The results of serum analysis are shown in Table 6 below.
총 콜레스테롤 수치의 경우 대조군과 비교하여 두 실험군에서 약간 증가하였지만 큰 차이를 보이지는 않았으며, 중성지방인 트리글리세리드의 경우 총 콜레스테롤과 마찬가지로 두 실험군에서 증가하였고, 대조군과 비교하여 실험군 2에서 약 2배 증가한 것을 알 수 있었다.Total cholesterol levels were slightly increased in the two experimental groups compared to the control group, but not significantly different. In the case of triglycerides, which were triglycerides, the total cholesterol level was increased in the two experimental groups as well as in the total cholesterol, .
또한, 고밀도 지질단백질-콜레스테롤(HDL-C) 및 저밀도 지질단백질- 콜레스테롤(LDL-C)의 경우 대조군과 비교하여 두 실험군 모두 고밀도 지질단백질-콜레스테롤의 수치를 증가시키는 것을 확인하였다. 초저밀도 지질단백질 콜레스테롤(VLDL-C)의 수치 또한 상기 결과와 유사한 경향을 보였다.In addition, high density lipoprotein-cholesterol (HDL-C) and low density lipoprotein-cholesterol (LDL-C) were found to increase the levels of high density lipoprotein-cholesterol in both groups compared with the control group. The values of the ultra-low density lipoprotein cholesterol (VLDL-C) also showed similar trends to the above results.
아울러, 포도당(glucose)의 경우 대조군과 비교하여 실험군 1에서 26.2%, 실험군 2에서 24.5% 감소하는 것을 확인하였다. In addition, glucose was reduced by 26.2% in the experimental group 1 and by 24.5% in the experimental group 2, compared with the control group.
상기 실험 결과들을 통하여 코코아 영양쉐이크 또는 쿠키 영양쉐이크를 섭취하는 경우 실험동물의 체중이 증가하고, 전장을 성장시키며, 고밀도 지질단백질 콜레스테롤의 수치를 증가시키고, 정상범위의 혈당을 유지하여 부작용 없이 체중을 증가시키는 것을 확인할 수 있었다. The results of the above experiment show that when the cocoa nutrition shake or cookie nutrition shake is consumed, the weight of the experimental animal is increased, the electric field is grown, the level of high density lipoprotein cholesterol is increased and the normal range of blood glucose is maintained, .
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to the preferred embodiments. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than by the foregoing description, and all differences within the scope of equivalents thereof should be construed as being included in the present invention.
Claims (2)
상기 조성물은 분리대두단백 50 중량%, 결정과당분말 18 중량%, 카제인나트륨 13 중량%, 멀티비타민 4 중량%, 쿠키향 분말 5 중량%, 꿀분말 4 중량%, 생크림향분말 4 중량%, 염화칼륨 1 중량% 및 이산화규소 1 중량%로 이루어지고,
상기 조성물은 쉐이크용 분말 제형이고,
상기 조성물은,
결정과당분말, 멀티비타민, 꿀분말, 쿠키향 분말, 염화칼륨 및 이산화규소를 혼합한 후 100 메쉬(mesh) 채망으로 여과 및 균질화하여 균질화 혼합물을 제조하는 단계; 및
상기 균질화 혼합물에 분리대두단백, 카제인나트륨 및 생크림향분말을 첨가한 후 60분 동안 혼합하는 단계
에 의하여 제조되고,
상기 조성물은 하루 총 용량 200 ㎎/㎏으로 경구 투여되는 것인
체중 증가용 식품 조성물.
In a food composition for weight gain,
The composition comprises 50% by weight of isolated soy protein, 18% by weight of crystalline fructose powder, 13% by weight of sodium caseinate, 4% by weight of multivitamin, 5% by weight of cookie flavor powder, 4% by weight of honey powder, 4% 1% by weight of silicon dioxide and 1% by weight of silicon dioxide,
Wherein the composition is a powder formulation for shaking,
The composition may comprise,
Preparing a homogenized mixture by mixing the fructose powder, the multivitamin, the honey powder, the cookie fragrance powder, the potassium chloride and the silicon dioxide, and then filtering and homogenizing the mixture with a 100 mesh mesh; And
Adding the separated soybean protein, sodium caseinate and cream fragrance powder to the homogenization mixture and mixing for 60 minutes
Lt; / RTI >
The composition is orally administered at a total dose of 200 mg / kg per day
Food composition for weight gain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160007817 | 2016-01-21 | ||
KR1020160007817 | 2016-01-21 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160148504A Division KR20170087819A (en) | 2016-01-21 | 2016-11-09 | Food composition for controlling body weight |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180098205A KR20180098205A (en) | 2018-09-03 |
KR101952078B1 true KR101952078B1 (en) | 2019-02-26 |
Family
ID=59418925
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160148504A KR20170087819A (en) | 2016-01-21 | 2016-11-09 | Food composition for controlling body weight |
KR1020180098993A KR101952078B1 (en) | 2016-01-21 | 2018-08-24 | Food composition for controlling body weight |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160148504A KR20170087819A (en) | 2016-01-21 | 2016-11-09 | Food composition for controlling body weight |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR20170087819A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210010229A (en) | 2019-07-19 | 2021-01-27 | 주식회사 엠시스템즈 | System and method for providing body weight management service |
KR102274627B1 (en) | 2021-03-12 | 2021-07-06 | 한상갑 | Manufacturing method for diet rice cake |
KR20220006685A (en) | 2020-07-08 | 2022-01-18 | 김혁 | Tandan juice and its manufacturing method |
KR20220008475A (en) | 2020-07-14 | 2022-01-21 | (주)리턴라이프 | Food composition for controlling body weight |
KR20230110105A (en) | 2022-01-14 | 2023-07-21 | (주)리턴라이프 | Protein food composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023195538A1 (en) * | 2022-04-08 | 2023-10-12 | ハニデュー株式会社 | Potato syrup powder formed from powder or granules of sweet potato syrup, supernatant thereof, or both |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033292A1 (en) | 2001-04-02 | 2004-02-19 | Robert Portman | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise |
KR101370312B1 (en) | 2012-11-05 | 2014-03-05 | 주식회사 비케이바이오 | Protein supplement food composition with improved solubility and manufacturing method thereof |
WO2015094767A1 (en) * | 2013-12-18 | 2015-06-25 | Abbott Laboratories | Methods for maintaining or increasing bodyweight using decaffeinated green tea extract |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5983601B2 (en) * | 2011-04-13 | 2016-08-31 | 味の素株式会社 | Nutritional composition |
-
2016
- 2016-11-09 KR KR1020160148504A patent/KR20170087819A/en active Search and Examination
-
2018
- 2018-08-24 KR KR1020180098993A patent/KR101952078B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033292A1 (en) | 2001-04-02 | 2004-02-19 | Robert Portman | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise |
KR101370312B1 (en) | 2012-11-05 | 2014-03-05 | 주식회사 비케이바이오 | Protein supplement food composition with improved solubility and manufacturing method thereof |
WO2015094767A1 (en) * | 2013-12-18 | 2015-06-25 | Abbott Laboratories | Methods for maintaining or increasing bodyweight using decaffeinated green tea extract |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210010229A (en) | 2019-07-19 | 2021-01-27 | 주식회사 엠시스템즈 | System and method for providing body weight management service |
KR20220006685A (en) | 2020-07-08 | 2022-01-18 | 김혁 | Tandan juice and its manufacturing method |
KR20220008475A (en) | 2020-07-14 | 2022-01-21 | (주)리턴라이프 | Food composition for controlling body weight |
KR102274627B1 (en) | 2021-03-12 | 2021-07-06 | 한상갑 | Manufacturing method for diet rice cake |
KR20230110105A (en) | 2022-01-14 | 2023-07-21 | (주)리턴라이프 | Protein food composition |
Also Published As
Publication number | Publication date |
---|---|
KR20170087819A (en) | 2017-07-31 |
KR20180098205A (en) | 2018-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101952078B1 (en) | Food composition for controlling body weight | |
ES2286070T3 (en) | FOOD PRODUCT CONTAINING VITAMIN K2. | |
CN104770743A (en) | Compound protein powder and preparing method thereof | |
WO2006132042A1 (en) | Nutritional supplement powder and fat for food or medicine | |
JP2010018522A (en) | Adiponectin production enhancer | |
Abzhanova et al. | Development of meat products for the nutrition of the elderly | |
RU2525338C2 (en) | Instant functional food product | |
CN104905309A (en) | Sauced pickled eels | |
CN103859040A (en) | Soy protein curd product and preparation method thereof | |
CN104585704A (en) | Mushroom vegetable seasoning and preparation method thereof | |
JP6081548B1 (en) | Method for producing food for persons with reduced motor function | |
KR20240109327A (en) | Food composition for weight gain | |
KR20230032538A (en) | Manufacturing method of vegetable protein bar containing spirulina | |
Prastyoningsih et al. | Formulation Of Instant Moringa Oleifera Combination Dates (Phoenix Dactylifera L.) As Galactogogues | |
RU2405354C1 (en) | Enriched curd mass for gerontological dietary alimentation | |
WO2018124202A1 (en) | Perspiration-promoting food composition | |
CN101190014B (en) | Raw cereal soy milk | |
CN102370145A (en) | Automatic nerve regulating agent with asparagus leaf as effective ingredient | |
JP2011153125A (en) | Autonomic control agent containing pseudo-leaf of asparagus as active ingredient | |
RU2712739C1 (en) | Method for production of functional purpose meat cream | |
CN106983125A (en) | Natural sweetened purpose compound flavour enhancer and its preparation method and application and the product comprising it | |
JP2872037B2 (en) | Edible eggs containing calcium and vitamin D at high concentrations and processed foods using the same | |
Rudavska et al. | New products for school food of the iodine deficiency biogeochemical provinces | |
Louis | Cannabis nutrition | |
KR101932274B1 (en) | Candy containing dried anchovy powder and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |